Downregulation of PLZF in human hepatocellular carcinoma and its clinical significance

Hui,Anselm   Wang-Hei; Lau,Hon-Wai; Cao,Cyanne  Ye; Zhou,Jun-Wei; Lai,Paul  Bo-San; Tsui,Stephen  Kwok-Wing

doi:10.3892/or.2014.3578

Downregulation of PLZF in human hepatocellular carcinoma and its clinical significance

Authors:
- Anselm Wang-Hei Hui
- Hon-Wai Lau
- Cyanne Ye Cao
- Jun-Wei Zhou
- Paul Bo-San Lai
- Stephen Kwok-Wing Tsui
View Affiliations

Affiliations: School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, SAR, P.R. China, Department of Surgery, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, SAR, P.R. China
Published online on: October 30, 2014 https://doi.org/10.3892/or.2014.3578
Pages: 397-402

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Promyelocytic leukemia zinc finger (PLZF) acts as a tumor-suppressor gene in a series of cancers including prostate, melanoma, colon cancer and leukemia. However, its role in hepatocellular carcinoma (HCC) has not yet been illustrated. The present study aimed to investigate the expression and epigenetic regulation of PLZF as well as its clinical significance in HCC. We found that the expression of PLZF was significantly downregulated in HCC samples at both the RNA level (P<0.001) and protein level compared with these levels in adjacent normal tissues. The relative expression level of PLZF was also positively correlated with the ALP level (P=0.026) noted in the HCC patients. However, hypermethylation was only detected in one out of 5 paired HCC samples, indicating that methylation of the selected promoter region (from -1702 to -1388) may not be the major regulatory mechanism for the downregulation of PLZF in HCC. A receiver operating characteristic (ROC) curve was created to evaluate the diagnostic value for differentiating between HCC and benign diseases. The area under the ROC curve (AUC) for indicating the value of PLZF as an HCC biomarker was 0.794 (95% CI, 0.697-0.892; P<0.001). Taken together, our results suggest that PLZF may play an important role in HCC development and may be a potential biomarker for the diagnosis of HCC.

View Figures

View References

1	Lau WY and Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int. 7:237–257. 2008.PubMed/NCBI
2	Hao K, Luk JM, Lee NP, Mao M, Zhang C, Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC and Poon RT: Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer. 9:3892009. View Article : Google Scholar : PubMed/NCBI
3	Lin DY, Huang CC, Hsieh YT, Lin HC, Pao PC, Tsou JH, Lai CY, Hung LY, Wang JM, Chang WC and Lee YC: Analysis of the interaction between Zinc finger protein 179 (Znf179) and promyelocytic leukemia zinc finger (Plzf). J Biomed Sci. 20:982013. View Article : Google Scholar : PubMed/NCBI
4	Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M, Orwig KE, Wolgemuth DJ and Pandolfi PP: Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet. 36:653–659. 2004. View Article : Google Scholar : PubMed/NCBI
5	Barna M, Hawe N, Niswander L and Pandolfi PP: Plzf regulates limb and axial skeletal patterning. Nat Genet. 25:166–172. 2000. View Article : Google Scholar : PubMed/NCBI
6	Buaas FW, Kirsh AL, Sharma M, McLean DJ, Morris JL, Griswold MD, de Rooij DG and Braun RE: Plzf is required in adult male germ cells for stem cell self-renewal. Nat Genet. 36:647–652. 2004. View Article : Google Scholar : PubMed/NCBI
7	Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JH, Zhu J, Dong S, Chen S, Chen Z, et al: Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci USA. 94:10255–10260. 1997. View Article : Google Scholar : PubMed/NCBI
8	McConnell MJ, Chevallier N, Berkofsky-Fessler W, Giltnane JM, Malani RB, Staudt LM and Licht JD: Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol Cell Biol. 23:9375–9388. 2003. View Article : Google Scholar : PubMed/NCBI
9	Vincent A, Omura N, Hong SM, Jaffe A, Eshleman J and Goggins M: Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma. Clin Cancer Res. 17:4341–4354. 2011. View Article : Google Scholar : PubMed/NCBI
10	Cheung M, Pei J, Pei Y, Jhanwar SC, Pass HI and Testa JR: The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival. Oncogene. 29:1633–1640. 2010. View Article : Google Scholar :
11	Brunner G, Reitz M, Schwipper V, Tilkorn H, Lippold A, Biess B, Suter L and Atzpodien J: Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients. Cancer Biother Radiopharm. 23:451–459. 2008. View Article : Google Scholar : PubMed/NCBI
12	Wang X, Wang L, Guo S, Bao Y, Ma Y, Yan F, Xu K, Xu Z, Jin L, Lu D, et al: Hypermethylation reduces expression of tumor-suppressor PLZF and regulates proliferation and apoptosis in non-small-cell lung cancers. FASEB J. 27:4194–4203. 2013. View Article : Google Scholar : PubMed/NCBI
13	Rho SB, Park YG, Park K, Lee SH and Lee JH: A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis. FEBS Lett. 580:4073–4080. 2006. View Article : Google Scholar : PubMed/NCBI
14	Vanyushin BF: Enzymatic DNA methylation is an epigenetic control for genetic functions of the cell. Biochemistry (Mosc). 70:488–499. 2005. View Article : Google Scholar
15	Snape WJ Jr, Long WB, Trotman BW, Marin GA and Czaja AJ: Marked alkaline phosphatase elevation with partial common bile duct obstruction due to calcific pancreatitis. Gastroenterology. 70:70–73. 1976.PubMed/NCBI
16	Ikeda R, Yoshida K, Tsukahara S, Sakamoto Y, Tanaka H, Furukawa K and Inoue I: The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1. J Biol Chem. 280:8523–8530. 2005. View Article : Google Scholar
17	Kotobuki N, Matsushima A, Kato Y, Kubo Y, Hirose M and Ohgushi H: Small interfering RNA of alkaline phosphatase inhibits matrix mineralization. Cell Tissue Res. 332:279–288. 2008. View Article : Google Scholar : PubMed/NCBI